Showing results (771-780 of 966) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.Nature Reviews. Clinical Oncology|December 5, 2020
Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapySatyen H Gohil, J Bryan Iorgulescu, David A Braun, et al.Nature Reviews. Clinical Oncology|November 11, 2020
The nuclear export protein XPO1 - from biology to targeted therapyAsfar S Azmi, Mohammed H Uddin, Ramzi M MohammadNature Reviews. Clinical Oncology|November 28, 2018
Integrating molecular nuclear imaging in clinical research to improve anticancer therapyElisabeth G E de Vries, Laura Kist de Ruijter, Marjolijn N Lub-de Hooge, et al.Nature Reviews. Clinical Oncology|February 28, 2018
Epigenome-based cancer risk prediction: rationale, opportunities and challengesMartin Widschwendter, Allison Jones, Iona Evans, et al.Nature Reviews. Clinical Oncology|February 26, 2021
Immunogenicity of CAR T cells in cancer therapyDimitrios L Wagner, Enrico Fritsche, Michael A Pulsipher, et al.Nature Reviews. Clinical Oncology|April 12, 2017
EMT, CSCs, and drug resistance: the mechanistic link and clinical implicationsTsukasa Shibue, Robert A WeinbergNature Reviews. Clinical Oncology|February 21, 2019
Therapeutic implications of germline genetic findings in cancerSubotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.Nature Reviews. Clinical Oncology|October 10, 2022
Clinical implications of T cell exhaustion for cancer immunotherapyAndrew Chow, Karlo Perica, Christopher A Klebanoff, et al.Nature Reviews. Clinical Oncology|February 9, 2021
Unlocking the potential of antibody-drug conjugates for cancer therapyJoshua Z Drago, Shanu Modi, Sarat ChandarlapatyPageof 97